Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection-Reference-Cited by-同舟云学术

Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection

Published:2022-03-25 Issue:12 Volume:101 Page:e29055
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yamamoto Masayo,Shindo Motohiro,Funayama Takuya,Sumi Chihiro,Saito Takeshi,Toki Yasumichi,Hatayama Mayumi,Imadome Ken-Ichi,Mizukami Yusuke,Okumura Toshikatsu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference15 articles.

1. Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation.;Ru;Eur J Haematol,2018

2. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogenic stem cell transplantation in high-risk patients.;Reddy;Biol Blood Marrow Transplant,2011

3. Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.;Ville;Transplant International,2018

4. Lymphoproliferative disorders after lung transplantation: clinicopathological characterization of 16 Cases with identification of very-late-onset forms.;Montpreville;Respiration,2015

5. Different causes of early and late-onset post transplant lymphoproliferative disorder in kidney transplantation patients after 2000.;Gwon;Asian J Surg,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare Co-occurrence of Spinal Cord Hemorrhage from Radiation-induced Cavernous Hemangioma and Classical Hodgkin Lymphoma Post-transplant Lymphoproliferative Disorder;Internal Medicine;2024

2. Exosomal transmission of viruses, a two-edged biological sword;Cell Communication and Signaling;2023-01-23

3. Multiple drugs;Reactions Weekly;2022-05